文献速递针灸推拿中医内科

针灸延缓正常眼压性青光眼视野缺损的随机对照试验

Efficacy and safety of acupuncture in slowing visual field loss in normal-tension glaucoma: A 24-week randomized controlled trial.
PubMed 文献 · Complement Ther Med · 2026-03-24

本研究为24周随机对照试验,纳入40例正常眼压性青光眼患者,比较每周一次针刺睛明与球后穴与王不留行籽假针刺的疗效。结果显示针刺组在24周时最佳矫正视力、视网膜神经纤维层厚度及眼压均较基线改善,且视野恶化速度显著慢于假针刺组,未报告治疗相关不良事件。

要点

  • 每周一次针刺睛明与球后穴可改善正常眼压性青光眼患者视力与视网膜结构。
  • 针刺组视野恶化速度显著慢于假针刺组,提示潜在神经保护作用。
  • 研究未报告治疗相关不良事件,支持针刺作为辅助治疗。

核心结论

  • 长期针刺可能有效保护正常眼压性青光眼患者的视功能与结构参数。

研究设计与样本

  • 24周随机对照试验,40例正常眼压性青光眼患者随机分为针刺组20例与假针刺组20例。

主要发现

  • 24周时针刺组右眼与左眼最佳矫正视力均较基线显著改善(右眼p=0.0102,左眼p=0.0128)。
  • 针刺组双眼视网膜神经纤维层厚度较基线增加(右眼p=0.0477,左眼p=0.0208)。
  • 针刺组双眼眼压较基线降低(右眼p=0.0430,左眼p=0.0401),假针刺组无上述改善。
  • 针刺组双眼视野恶化速度显著慢于假针刺组(p<0.05)。
  • 未报告治疗相关不良事件。

关键数值与推荐

  • 针刺方案为每周一次,取穴睛明(BL1)与球后(EX-HN7)。
  • 假针刺为同部位王不留行籽贴压。

临床怎么用

  • 可考虑将每周一次针刺睛明与球后穴作为正常眼压性青光眼的辅助治疗。
  • 需关注针刺对最佳矫正视力、视网膜神经纤维层厚度及眼压的改善作用。

局限性

  • 样本量较小(40例),需更大规模双盲多中心试验进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Normal-tension glaucoma (NTG) is a progressive optic neuropathy for which effective treatment strategies remain limited. We previously demonstrated that short-term (2-week) acupuncture can reduce intraocular pressure (IOP). In this study, we investigated the long-term efficacy and safety of acupuncture on visual function and structural parameters in NTG patients. METHODS: In this 24-week randomized controlled trial, 40 patients with NTG received once-weekly acupuncture at the Jingming (BL1) and Qiuhou (EX-HN7) acupoints (n = 20) or sham acupuncture with Vaccaria seeds (Wang-Bu-Liu-Xing) (n = 20) at the same locations. RESULTS: At 24 weeks, the true acupuncture group significantly improved their best-corrected visual acuity (BCVA) from baseline in both the right (p = 0.0102) and left (p = 0.0128) eyes, increased retinal nerve fiber layer (RNFL) thickness in both eyes (right: p = 0.0477; left: p = 0.0208), and reduced IOP (right: p = 0.0430; left: p = 0.0401). No such improvements were observed with sham acupuncture. The rate of visual field deterioration was also significantly slower with true acupuncture compared with sham acupuncture (p < 0.05 for both eyes). No adverse treatment-related events were reported. CONCLUSION: This is the first clinical trial to demonstrate that long-term acupuncture may effectively preserve both structural and functional visual parameters in patients with NTG, suggesting a potential neuroprotective effect of acupuncture and supporting its role as a promising adjunctive therapy. Further validation is warranted with larger, double-blind, multicenter trials.

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Chen SY, Yieh FS, Wu PY, et al. Efficacy and safety of acupuncture in slowing visual field loss in normal-tension glaucoma: A 24-week randomized controlled trial. Complement Ther Med. 2026. PMID: 41887338. doi:10.1016/j.ctim.2026.103363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。